Physician profile

William A Tucker

Orthopaedic Surgery · Corpus Christi, TX

NPI 1922088095

$14,554.79

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$9,300.00
Food and Beverage$170.20
Travel and Lodging$86.60

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Omnilife Science, INC $11,980.74 2021-2023 Omnibotics 3.0
Zimmer Biomet Holdings, INC. $1,839.57 2021-2022
Stryker Corporation $318.86 2022-2024 Mako, Gamma
Smith+Nephew, INC. $187.08 2019-2022
Carbofix Orthopedics INC $109.21 2021
Depuy Synthes Sales INC. $68.55 2020-2023 Tfn-Advance, Na
Avanos Medical $30.11 2022
W. L. Gore & Associates, INC. $20.67 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

William A Tucker

$14,554.79

in general payments reported 2019-2025

Years
2019-2024
Top company
Omnilife Science, INC

https://glasscript.com/doctor/87313/william-a-tucker

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.